Cell aggregation assays have typically been used as a direct test for the functional integrity of E-cadherin-catenin complexes and therefore as a tool to study invasive and non-invasive cell types in cancer (Debruyne et al., 2014). This evidence concerns the gene CDH1 and cancer.